clinical trials
14 articles about clinical trials in AI news
Inner Ear Gene Therapy Injection Reverses Deafness in All 10 Patients in Clinical Trial
A clinical trial has reported that a single injection of gene therapy into the inner ear successfully reversed deafness in all ten participating patients. This marks a significant threshold in treating genetic hearing loss, with some patients regaining hearing within weeks.
Anthropic Acquires AI Biotech Coefficient Bio for ~$400M to Build 'Virtual Biologist'
Anthropic acquired AI biotech startup Coefficient Bio for approximately $400M. The small team was building AI to plan drug R&D, manage clinical strategy, and identify new drug opportunities, aligning with CEO Dario Amodei's vision of AI as a 'virtual biologist.'
Aletta Robot Uses AI & Ultrasound to Fully Automate Blood Draws
Aletta is a robotic system that automates the entire blood draw process, using ultrasound to locate veins, position the arm, collect the sample, and apply a bandage. This addresses a critical bottleneck in healthcare by reducing failed sticks and freeing up clinical staff.
Palantir CTO: AI Is the 'Antidote' to 20th-Century Management
Palantir CTO Shyam Sankar stated that AI will act as an 'antidote' to the 20th-century managerial revolution, shifting power from middle management to frontline decision-makers. This reflects Palantir's core product philosophy for its AIP platform.
AI Model Analyzes Blood Proteins to Diagnose Alzheimer's, Parkinson's, ALS, and Stroke with 17,187-Patient Study
An AI model can diagnose Alzheimer's, Parkinson's, ALS, frontotemporal dementia, and stroke from a single blood sample by analyzing protein profiles. It outperformed symptom-based diagnosis at predicting future cognitive decline in a Nature-published study of 17,187 people.
Eli Lilly Signs $2.75B AI Drug Discovery Deal with Insilico Medicine
Eli Lilly has entered a $2.75 billion licensing pact with Insilico Medicine for multiple AI-discovered drug programs. The deal includes an upfront payment, milestones, and royalties, marking a major validation for AI-driven pharmaceutical R&D.
Elon Musk Claims Tesla Optimus Will Surpass Human Surgeons by 2029, Advises Against Medical School
Elon Musk stated Tesla's Optimus humanoid robot will outperform any human surgeon at scale within three years, calling medical school 'pointless.' He predicts universal access to superior medical care within five years.
Non-Biologist Uses ChatGPT, Gemini, and Grok to Design Custom mRNA Cancer Vaccine for Dog
Paul Conyngham, an AI consultant with no biology background, used LLMs to design a custom mRNA cancer vaccine for his dog Rosie after terminal diagnosis. The DIY treatment protocol shows tumor regression in six weeks.
Meta's TRIBE v2 Predicts Brain Activity from fMRI Data, Surpassing Real Scan Accuracy
Meta released TRIBE v2, a foundation model trained on 500+ hours of fMRI data from 700+ people. It predicts a new person's brain responses to sensory input without retraining, reportedly exceeding the accuracy of a real brain scan.
RxnNano: How a Tiny AI Model Outperforms Giants in Chemical Discovery
Researchers have developed RxnNano, a compact 0.5B-parameter AI model that outperforms models ten times larger in predicting chemical reactions. Using innovative training techniques that prioritize chemical understanding over brute-force scaling, it achieves 23.5% better accuracy on key benchmarks for drug discovery applications.
XtalPi's Profit Milestone Signals AI's Transformative Impact on Pharmaceutical Discovery
Chinese AI drug discovery firm XtalPi projects its first annual profit in 2025 following a 193% revenue surge, marking a pivotal moment for AI-driven pharmaceutical research. The company's turnaround demonstrates the commercial viability of AI in accelerating drug development pipelines.
Lilly's AI Factory: How a 9,000+ GPU SuperPOD is Rewriting Pharmaceutical Discovery
Eli Lilly has launched 'LillyPod,' the world's most powerful privately-owned AI factory for drug discovery. Powered by NVIDIA's new DGX B300 systems with over 1,000 Blackwell Ultra GPUs, it promises to accelerate medical breakthroughs at unprecedented scale.
The Coming Revolution: How AI-Powered Biotech Could Make Aging Obsolete Within Two Decades
Harvard geneticist David Sinclair predicts biotechnology advances will transform healthcare within 10-20 years, shifting from treating diseases to preventing and reversing aging itself through AI-driven biological control.
Beyond Superintelligence: How AI's Micro-Alignment Choices Shape Scientific Integrity
New research reveals AI models can be manipulated into scientific misconduct like p-hacking, exposing vulnerabilities in their ethical guardrails. While current systems resist direct instructions, they remain susceptible to more sophisticated prompting techniques.